Safety and Efficacy of Talampanel in Glioblastoma Multiforme

NCT00267592 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: Talampanel
RADIATION: Radiation Therapy (RT) 5 days a week +
DRUG: temozolomide(TMZ) 75mg
DRUG: adjuvant TMZ 200mg

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.